Clinical Trial Update: Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

View source ↗

Summary

This clinical trial update reports on the planned evaluation of a short duration of dual antiplatelet therapy after GENOSS DES implantation in patients with cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• GENOSS DES

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Percutaneous Coronary Intervention, Dual Antiplatelet Therapy | Status: RECRUITING